Isozaki Y - Search Results

1

A Phase I/II Trial of Definitive Carbon Ion Radiotherapy for Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.

Isozaki T, Ishikawa H, Yasuda S, Isozaki Y, Yamada S, Akutsu Y, Nagata M, Nabeya Y, Minashi K, Murakami K, Kuwano H, Nemoto K, Tsuji H, Uno T, Matsubara H. Isozaki T, et al. Among authors: isozaki y. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):416-421. doi: 10.1016/j.ijrobp.2023.04.014. Epub 2023 Apr 26. Int J Radiat Oncol Biol Phys. 2023. PMID: 37116590 Clinical Trial. No abstract available.

2

Carbon-Ion Radiation Therapy for Pelvic Recurrence of Rectal Cancer.

Yamada S, Kamada T, Ebner DK, Shinoto M, Terashima K, Isozaki Y, Yasuda S, Makishima H, Tsuji H, Tsujii H, Isozaki T, Endo S, Takahashi K, Sekimoto M, Saito N, Matsubara H; Working Group on Locally Recurrent Rectal Cancer. Yamada S, et al. Among authors: isozaki y, isozaki t. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):93-101. doi: 10.1016/j.ijrobp.2016.04.022. Epub 2016 Apr 23. Int J Radiat Oncol Biol Phys. 2016. PMID: 27375166 Clinical Trial.

3

Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.

Kawashiro S, Yamada S, Okamoto M, Ohno T, Nakano T, Shinoto M, Shioyama Y, Nemoto K, Isozaki Y, Tsuji H, Kamada T. Kawashiro S, et al. Among authors: isozaki y. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1212-1221. doi: 10.1016/j.ijrobp.2018.04.057. Epub 2018 May 1. Int J Radiat Oncol Biol Phys. 2018. PMID: 29907490

4

The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.

Akutsu Y, Shuto K, Kono T, Uesato M, Hoshino I, Shiratori T, Isozaki Y, Akanuma N, Uno T, Matsubara H. Akutsu Y, et al. Among authors: isozaki y. J Surg Oncol. 2012 Jun 15;105(8):756-60. doi: 10.1002/jso.23007. Epub 2011 Dec 12. J Surg Oncol. 2012. PMID: 22162007

5

A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedaplatin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma.

Akutsu Y, Shuto K, Kono T, Uesato M, Hoshino I, Shiratori T, Miyazawa Y, Isozaki Y, Akanuma N, Matsubara H. Akutsu Y, et al. Among authors: isozaki y. Hepatogastroenterology. 2012 Oct;59(119):2095-8. doi: 10.5754/hge11952. Hepatogastroenterology. 2012. PMID: 22328303 Clinical Trial.

6

Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.

Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N, Maruyama T, Seki N, Nishino N, Yoshida M, Matsubara H. Isozaki Y, et al. Int J Oncol. 2012 Sep;41(3):985-94. doi: 10.3892/ijo.2012.1537. Epub 2012 Jun 28. Int J Oncol. 2012. PMID: 22752059

7

miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.

Takeshita N, Mori M, Kano M, Hoshino I, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Miyazawa Y, Matsubara H. Takeshita N, et al. Among authors: isozaki y. Int J Oncol. 2012 Nov;41(5):1653-61. doi: 10.3892/ijo.2012.1614. Epub 2012 Aug 30. Int J Oncol. 2012. PMID: 22940702

8

A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma.

Yusup G, Akutsu Y, Mutallip M, Qin W, Hu X, Komatsu-Akimoto A, Hoshino I, Hanari N, Mori M, Akanuma N, Isozaki Y, Matsubara H. Yusup G, et al. Among authors: isozaki y. Int J Oncol. 2014 Apr;44(4):1146-52. doi: 10.3892/ijo.2014.2300. Epub 2014 Feb 14. Int J Oncol. 2014. PMID: 24535229

9

Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map.

Isozaki Y, Hoshino I, Akutsu Y, Hanari N, Mori M, Nishimori T, Murakami K, Akanuma N, Toyozumi T, Takahashi M, Suito H, Takeshita N, Maruyama T, Suzuki A, Nakayama T, Matsubara H. Isozaki Y, et al. Oncology. 2014;87(6):351-63. doi: 10.1159/000365592. Epub 2014 Sep 5. Oncology. 2014. PMID: 25195536

10

Usefulness of microRNA‑375 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma.

Isozaki Y, Hoshino I, Akutsu Y, Hanari N, Mori M, Nishimori T, Murakami K, Akanuma N, Takeshita N, Maruyama T, Toyozumi T, Takahashi M, Suito H, Matsubara H. Isozaki Y, et al. Int J Oncol. 2015 Mar;46(3):1059-66. doi: 10.3892/ijo.2014.2789. Epub 2014 Dec 9. Int J Oncol. 2015. PMID: 25501018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page